AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
25 hedge funds and large institutions have $5.47M invested in Agile Therapeutics in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
25
Holding in Top 10
1
Calls
$87K
Puts
–
Top Buyers
| 1 | +$413K | |
| 2 | +$131K | |
| 3 | +$25.3K | |
| 4 |
BlackRock
New York
|
+$10.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7K |
Top Sellers
| 1 | -$227K | |
| 2 | -$86.3K | |
| 3 | -$49.2K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$34K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$24K |